ALZAMEND NEURO, INC. Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds
ALZAMEND NEURO, INC. (ALZN) reported Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds of $14.40 million for the 1-month period ending 2021-06-17, per its 10-K filed 2023-07-27.
Discontinued › Notes › Financial Services › Demutualization and Closed Block
us-gaap:DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds · last filed 2023-07-27
- 2021-06-17: Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds 1 month $14.40M.
| Period end | Demutualization by Insurance Entity, Securities Issued, Gross Cash Proceeds 1 month |
|---|---|
| 2021-06-17 | $14.40M 10-K · filed 2023-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |